explore -WSS

explore

author：knowledge 2025-08-19 20:45:01 - browse：1

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： FDA approves first treatment for ultra

WSS

Hilary may become 1st tropical storm to make landfall in California in 84 years

BridgeBio heart drug succeeds in pivotal study

Manchin plays down potential 3rd

Trump's false claims about Georgia's 2020 election long debunked

Flagship, Pfizer team up in deal worth up to $7 billion

ER docs worry over extreme heat as a 'mass casualty event'

focus

explore

explore

In Memoriam: Notable people who died in 2023

An interview with Robert F. Kennedy Jr. on vaccines

23andMe had bad news about my health. I wish a person had delivered it

ProMED sees offers of support, but its future remains unclear

Supreme Court strikes down use of affirmative action

Flagship, Pfizer team up in deal worth up to $7 billion

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: Racing for gene therapy & a pioneering approval

Apple is now the first public company to be valued at $3 trillion

Trump cancels press conference intended to dispute Georgia election interference charges

hotspot

Ukraine taking heavy casualties 10 weeks into its counteroffensive

FDA seeking to stop procedures at two unregulated stem cell clinics

Baltimore teen accused of firing into crowd during block party mass shooting

A Theranos scientist

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

explore

entertainment

leisure time

explore